خلاصہ: November 17 2025 – J&J, aiming for $50b in cancer sales, buys Halda for $3b in cash
admin
Mon, 11/17/2025 – 11:29
J&J, aiming for $50b in cancer sales, buys Halda for $3b in cash
JNJ board
Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic
Novo Nordisk board
Lilly bets more than $2.6B for South Korea biotech’s bispecific antibody platform
Eli Lilly board
BMS, J&J give up on milvexian for acute coronary syndrome
Bristol Myers Squibb board, JNJ board
*please scroll down for all the latest news*
Layoff discussions
Check open job listings in your area
Click here to the top four headlines in your inbox Mon-Fri (free)
learn about pharmaceutical fraud
learn about the False Claims Act

